Cargando…

TBIO-12. Screening for Cancer Predisposition Syndromes in Pediatric Neuro-Oncology Patients: a Single Institution Experience

BACKGROUND: Traditional screening for cancer predisposition syndromes centers on family history, phenotypic features, and tumor histology. With expanded accessibility of next generation sequencing, identification of de novo germline mutations is increasing and the predictive value of family history...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johns, Claire, Kline, Cassie, Solomon, David, Mueller, Sabine, Banerjee, Anu, Gupta, Nalin, Reddy, Alyssa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Tumor Biology (not fitting a specific disease category)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165024/ http://dx.doi.org/10.1093/neuonc/noac079.694

Ejemplares similares

TBIO-24. USING MOLECULAR GUIDED THERAPY IN PEDIATRIC NEURO ONCOLOGY PATIENTS: THE SUCCESS AND BARRIERS
por: Armstrong, Beth, et al.
Publicado: (2020)

TBIO-03. Angiogenesis in Pituitary Adenoma
por: Yoshida, Daizo, et al.
Publicado: (2022)

TBIO-27. RASOPATHIES AND BRAIN TUMOROGENESIS: ARE SOS1 MUTATIONS ARE CONCERNED?
por: Abdelmoula, Nouha Bouayed, et al.
Publicado: (2020)

TBIO-09. EZHIP is not expressed within the developing mouse or human brain
por: Talal Younes, Subhi, et al.
Publicado: (2022)

TBIO-01. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA
por: Sponagel, Jasmin, et al.
Publicado: (2020)

TBIO-18. ESTABLISHING A PIPELINE FOR INDIVIDUALIZED TREATMENT OPTIONS FOR PEDIATRIC BRAIN CANCER
por: Djirackor, Luna, et al.
Publicado: (2020)

TBIO-19. INTEGRATED GENOMIC, PROTEOMIC AND PHOSPHOPROTEOMIC ANALYSIS OF SEVEN TYPES OF PEDIATRIC BRAIN CANCER
por: Petralia, Francesca, et al.
Publicado: (2020)

TBIO-06. BDNF-TRKB SIGNALING REGULATES NEURON-GLIOMA SYNAPTOGENESIS AND PROMOTES TUMOR PROGRESSION
por: Taylor, Kathryn, et al.
Publicado: (2020)

TBIO-02. Mapping the origins of pediatric brain tumors to cell type lineages in the developing cerebellum.
por: Okonechnikov, Konstantin, et al.
Publicado: (2022)

TBIO-01. Mutation Profiling of Paediatric Solid Tumours in a Cohort of South African Patients
por: Lamola, Lindiwe, et al.
Publicado: (2022)

TBIO-07. Pediatric tumor classification through genome-wide methylation profiling of extracellular vesicle DNA
por: Ricklefs, Franz, et al.
Publicado: (2022)

TBIO-26. NON-CANONICAL OPEN READING FRAMES ENCODE FUNCTIONAL PROTEINS ESSENTIAL FOR CANCER CELL SURVIVAL
por: Prensner, John, et al.
Publicado: (2020)

TBIO-12. THE SPECTRUM OF MITOCHONDRIAl DNA (mtDNA) MUTATIONS IN PEDIATRIC CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Kaneva, Kristiyana, et al.
Publicado: (2020)

TBIO-13. USE OF NEXT GENERATION SEQUENCING TO IDENTIFY MOVE DRIVERS OF CRYPTIC, CLINICALLY AGGRESSIVE BRAIN TUMORS
por: Younes, Subhi Talal, et al.
Publicado: (2020)

TBIO-17. INTEGRATIVE ANALYSES OF BRAFv600e MUTATED GLIOMAS: FROM MOLECULAR BIOLOGY TO RADIOLOGY AND TREATMENTS
por: Lhermitte, Benoit, et al.
Publicado: (2020)

TBIO-14. CHARACTERISATION OF THE ARGININE PATHWAY ENZYMES IN PAEDIATRIC BRAIN TUMOURS TO DETERMINE SUSCEPTIBILITY TO THERAPEUTIC ARGININE DEPLETION
por: Bishop, Eleanor, et al.
Publicado: (2020)

TBIO-05. GENOME-SCALE NUCLEOTIDE-SPECIFIC CHARACTERIZATION OF 5-HYDROXYMETHYLCYTOSINE IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
por: Azizgolshani, Nasim, et al.
Publicado: (2020)

TBIO-03. THE GIFT FROM A CHILD PROGRAM IS EMPOWERING POST-MORTEM TISSUE DONATION ACROSS THE UNITED STATES
por: Waanders, Angela, et al.
Publicado: (2020)

TBIO-09. IN SILICO ANALYSIS IDENTIFIES A PUTATIVE CELL-OF-ORIGIN FOR BRAF FUSION-POSITIVE CEREBELLAR PILOCYTIC ASTROCYTOMA
por: Younes, Subhi Talal
Publicado: (2020)

TBIO-15. MODELING DEVELOPMENTAL GENE EXPRESSION DYNAMICS AT CELLULAR RESOLUTION TO INTERPRET PEDIATRIC BRAIN TUMOR TRANSCRIPTIONAL PROGRAMS
por: Jessa, Selin, et al.
Publicado: (2020)

TBIO-16. NOTCH1 PATHWAY AS TARGET FOR DRUG INTERVENTION FOR HISTONE 3 G34R MUTATED pHGG
por: Foot, Katie, et al.
Publicado: (2020)

TBIO-11. DEEP LEARNING-BASED SINGLE-CELL RNA SEQUENCING DIFFERENTIATION IDENTIFIES SIMPLE AND COMPLEX TRANSCRIPTIONAL NETWORKS FOR SUBPOPULATION CLASSIFICATION
por: Prince, Eric, et al.
Publicado: (2020)

TBIO-07. SINGLE-CELL TRANSCRIPTOMIC PROFILE REVEALS MACROPHAGE HETEROGENEITY IN SONIC-HEDGEHOG MEDULLOBLASTOMA AND THEIR DISTINCT RESPONSES TO DIFFERENT TREATMENT MODALITIES
por: Dang, Mai, et al.
Publicado: (2020)

TBIO-02. IMMUNE PROFILING OF RARE EMBRYONAL BRAIN TUMORS REVEAL EVIDENCE OF DYSREGULATED INTERFERON SIGNALLING AS A POTENTIAL DETERMINANT OF IMMUNOLOGICAL HETEROGENEITY
por: Popovski, Dean, et al.
Publicado: (2020)

TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3.3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS
por: Sangatsuda, Yuhei, et al.
Publicado: (2020)

TBIO-21. Lnc-TALC PROMOTES O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE EXPRESSION VIA REGULATING THE C-MET PATHWAY BY COMPETITIVELY BINDING WITH miR-20b-3p
por: Wu, Pengfei, et al.
Publicado: (2020)

OTHR-08. Pediatric Neurologic Assessment in Neuro-oncology (pNANO) Scale: A tool to assess neurologic function for Response Assessment in Neuro-oncology (RAPNO)
por: Malbari, Fatema, et al.
Publicado: (2022)

OTHR-20. Precision neuro-oncology in the real world. Opportunity and challenges from a UK Oncology Centre
por: Apps, John, et al.
Publicado: (2022)

OTHR-12. Incidentalomas; should benign, indeterminate MRI findings be discussed at the paediatric neuro-oncology MDT
por: Large, Alexandra, et al.
Publicado: (2022)

OTHR-06. NARRATIVE MEDICINE AND THE PRACTICE OF PEDIATRIC NEURO-ONCOLOGY: GRAPPLING WITH THE UNTHINKABLE
por: Riley, Kathy, et al.
Publicado: (2023)

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
por: Foster, Jessica B., et al.
Publicado: (2023)

OTHR-11. THE IMPORTANCE AND INFLUENCE OF PATIENT FAMILY INVOLVEMENT IN PEDIATRIC NEURO-ONCOLOGY RESEARCH
por: Lyons, Nicole, et al.
Publicado: (2023)

OTHR-44. Building narrative competence on the neuro-oncology team: a narrative medicine approach to fostering unity and resilience for work with pediatric brain tumor families
por: Riley, Kathy
Publicado: (2022)

SWK-10. TELEHEALTH IN OUTPATIENT PEDIATRIC NEURO-ONCOLOGY CARE
por: Raber, Shannon, et al.
Publicado: (2020)

GLIOMA-07 E.R.A.S. IN NEURO-ONCOLOGY
por: Moro, Mario
Publicado: (2023)

OTHER-14 NEURO-ONCOLOGY STAFF MEETING: EXPERIENCE OF 4 YEARS
por: Drogba, Landry, et al.
Publicado: (2023)

OUTC-08. IMPLEMENTING SOCIAL DETERMINANT OF HEALTH DATA COLLECTION FOR PEDIATRIC, ADOLESCENT AND YOUNG ADULT NEURO-ONCOLOGY PATIENTS IN THE CLINICAL TRIAL CONSORTIA SETTING: PROGRESS AND CHALLENGES
por: Puthenpura, Vidya, et al.
Publicado: (2023)

OTHR-41. Amplification of the PLAG family genes – PLAGL1 and PLAGL2 – is a key feature of a novel embryonal CNS tumor type
por: Keck, Michaela-Kristina, et al.
Publicado: (2022)

OTHR-04. DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM
por: Peterziel, Heike, et al.
Publicado: (2023)

OTHR-02. MULTIMODALITY TREATMENT FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) TUMOR IN OUR INSTITUTE
por: Sasano, Mari, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9mecnun2bf82kgtj00vs2j9ken